What is he best known for?
The fields of study he is best known for:
John C. Reed mostly deals with Apoptosis, Cell biology, Programmed cell death, Molecular biology and Cancer research.
His Apoptosis research integrates issues from Cell and Cancer.
His research in Cell biology tackles topics such as Mitochondrial permeability transition pore which are related to areas like Cyclosporin a.
His study in Programmed cell death is interdisciplinary in nature, drawing from both Neoplastic cell and Cytotoxic T cell.
John C. Reed interconnects Cell culture, In vitro and Gene product, Gene expression, Gene in the investigation of issues within Molecular biology.
John C. Reed has researched Cancer research in several fields, including Survivin, Carcinogenesis, Cancer cell and Leukemia, Immunology.
His most cited work include:
- Mitochondria and apoptosis (8126 citations)
- Tumor suppressor p53 is a direct transcriptional activator of the human bax gene (3610 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
What are the main themes of his work throughout his whole career to date?
John C. Reed focuses on Apoptosis, Cell biology, Molecular biology, Programmed cell death and Cancer research.
His Apoptosis study integrates concerns from other disciplines, such as Cell culture, Cell and Cancer.
The concepts of his Cell biology study are interwoven with issues in Receptor and Biochemistry.
His Molecular biology research includes themes of Gene expression, Gene and Transfection.
His biological study spans a wide range of topics, including In vitro and Pathology.
His Cancer research research incorporates themes from Cancer cell, Carcinogenesis and Chronic lymphocytic leukemia, Leukemia, Immunology.
He most often published in these fields:
- Apoptosis (41.29%)
- Cell biology (36.42%)
- Molecular biology (28.36%)
What were the highlights of his more recent work (between 2010-2019)?
- Cell biology (36.42%)
- Cancer research (25.17%)
- Apoptosis (41.29%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cell biology, Cancer research, Apoptosis, Immunology and Programmed cell death.
John C. Reed focuses mostly in the field of Cell biology, narrowing it down to matters related to Autophagy and, in some cases, Cysteine protease.
His research in Cancer research intersects with topics in Carcinogenesis, Cancer, Prostate cancer, Cell culture and Leukemia.
His work deals with themes such as Cancer cell and In vivo, which intersect with Apoptosis.
His Immunology research is multidisciplinary, incorporating perspectives in Myeloid Cell Leukemia Sequence 1 Protein and Receptor.
Programmed cell death is a subfield of Genetics that John C. Reed explores.
Between 2010 and 2019, his most popular works were:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- ER stress-induced cell death mechanisms (1082 citations)
- Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics (252 citations)
In his most recent research, the most cited papers focused on:
John C. Reed mainly focuses on Cell biology, Apoptosis, Cancer research, Signal transduction and Autophagy.
His studies deal with areas such as Inflammasome and Programmed cell death as well as Cell biology.
His Programmed cell death research focuses on subjects like Pathology, which are linked to Brain damage, Caspase 8 and Cerebral cortex.
His Apoptosis research focuses on Cancer cell and how it relates to Cytotoxicity.
His work carried out in the field of Cancer research brings together such families of science as Cancer, Leukemia, Immunology and Cell culture.
His Signal transduction study also includes
- Ubiquitin ligase which connect with BAX inhibitor 1, Protein folding, Gene knockdown, Molecular biology and Mutant,
- Ubiquitin which connect with Phagosome and ATG8.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
